Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/FIVE-PRIME-THERAPEUTICS-I-14297720/news/Five-Prime-Announces-Abstract-with-Updated-Data-in-Mesothelioma-Patients-from-Ongoing-Phase-1b-Trial-25049613/?utm_source=whatsapp&utm_medium=social&utm_campaign=share